Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply
Alimentary Pharmacology & Therapeutics · 2024
DOI: 10.1111/apt.17788 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Chien-Hung Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicin…. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Antiviral Agents. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
LINKED CONTENT This article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.17602 and https://doi.org/10.1111/apt.17767
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
- Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
- School of Medicine, China Medical University, Taichung, Taiwan.
ORCID-Profile: Chien-Hung Chen, Cheng-Yuan Peng
Zitieren
APA
Chen, C. H., & Peng, C. Y. (2024). Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17788
Vancouver
Chen CH, Peng CY. Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17788
BibTeX
@article{Chen2024,
author = {Chen, Chien-Hung and Peng, Cheng-Yuan},
title = {Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
doi = {10.1111/apt.17788}
}
EUVIMED